999 resultados para 02241750 CTD-99
Resumo:
This paper proposes some reflections from activities developped in the context of a research supported by FAPESP called “As políticas de educação profissional e tecnológica no Brasil pós LDB 9394/96”. Our purpose is to analyze the federal legislation of professional and technological education, by enphasizing its impacts in technical schools of São Paulo (Brazil).
Resumo:
The nature of the dark matter in the Universe is one of the greatest mysteries in modern astronomy. The neutralino is a nonbaryonic dark matter candidate in minimal supersymmetric extensions to the standard model of particle physics. If the dark matter halo of our galaxy is made up of neutralinos some would become gravitationally trapped inside massive bodies like the Earth. Their pair-wise annihilation produces neutrinos that can be detected by neutrino experiments looking in the direction of the centre of the Earth. The AMANDA neutrino telescope, currently the largest in the world, consists of an array of light detectors buried deep in the Antarctic glacier at the geographical South Pole. The extremely transparent ice acts as a Cherenkov medium for muons passing the array and using the timing information of detected photons it is possible to reconstruct the muon direction. A search has been performed for nearly vertically upgoing neutrino induced muons with AMANDA-B10 data taken over the three year period 1997-99. No excess above the atmospheric neutrino background expectation was found. Upper limits at the 90 % confidence level has been set on the annihilation rate of neutralinos at the centre of the Earth and on the muon flux induced by neutrinos created by the annihilation products.
Resumo:
Se han eliminado páginas en blanco
Resumo:
BACKGROUND: We evaluated previously established regimens of capecitabine plus vinorelbine in older patients with advanced breast cancer stratified for presence versus absence of bone metastases. PATIENTS AND METHODS: Patients > or =65 years who had received no prior chemotherapy for advanced breast cancer received up to six 21-day cycles of vinorelbine 20 mg/m(2) i.v. on days 1 + 8 with oral capecitabine on days 1-14 (1,000 vs. 1,250 mg/m(2) daily in patients with vs. without bone involvement). RESULTS: Median age was 72 years in patients with bone metastases (n = 47) and 75 years in patients without bone metastases (n = 23). Response rates were 43% (95% confidence interval, CI, 28.3-58.8) and 57% (95% CI = 34.5-76.8), respectively. Median time to progression was 4.3 (95% CI = 3.5-6.0 months) and 7.0 months (CI = 4.1-8.3), respectively. Neutropenia was the most common toxicity, with grade 3/4 occurring in 43 and 39%, respectively. Pulmonary embolism was seen in 5 and grade 3 thrombosis in 3 patients. Other toxicities were mild to moderate. CONCLUSIONS: These regimens of capecitabine and vinorelbine are active and well tolerated in patients with advanced breast cancer > or =65 years. Response rates were comparable to published results. The lower capecitabine doses appeared appropriate given the advanced age, bone involvement and prior radiotherapy.
Resumo:
R. H. Charles
Resumo:
Vorbesitzer: Eljāqīm Carmoly; Abraham Merzbacher